Live Poll Results — In 2022, which company became the first major insulin manufacturer to voluntaril
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Price Revolution: The Historic Insulin Price Cap
The pricing of life-saving medications has long been a contentious issue in the medical industry. In recent years, certain medications have seen dramatic price changes due to policy interventions, public pressure, or market forces. This poll tests your knowledge about a significant pricing policy change that affected millions of patients with diabetes in the United States.
In 2022, which company became the first major insulin manufacturer to voluntarily cap patient out-of-pocket costs at $35 per month for all its insulin products in the US?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Eli Lilly', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Novo Nordisk', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Sanofi', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Merck', 'is_correct': False} | 0 | 0% |